ABSTRACT
Phosphorylation of the α subunit of the translation initiation factor eIF2 at serine 51 (eIF2αP) is a master regulator of cell adaptation to various forms of stress with implications in antitumor treatments with chemotherapeutic drugs. Herein, we demonstrate that genetic loss of the eIF2α kinases PERK and GCN2 or impaired eIF2αP by genetic means renders immortalized mouse fibroblasts as well as human tumor cells increasingly susceptible to death by oxidative stress. We also show that eIF2αP facilitates Akt activation in cells subjected to oxidative insults. However, whereas Akt activation has a pro-survival role in eIF2αP-proficient cells, the lesser amount of activated Akt in eIF2αP-deficient cells promotes death. At the molecular level, we demonstrate that eIF2αP acts through an ATF4-independent mechanism to control Akt activity via the regulation of mTORC1. Specifically, eIF2αP downregulates mTORC1 activity, which in turn relieves the feedback inhibition of PI3K resulting in the upregulation of the mTORC2-Akt arm. Inhibition of mTORC1 by rapamycin restores Akt activity in eIF2αP-deficient cells but renders them highly susceptible to Akt-mediated death by oxidative stress. Our data demonstrate that eIF2αP acts as a molecular switch that dictates either cell survival or death by activated Akt in response to oxidative stress. Hence, we propose that inactivation of eIF2αP may be a suitable approach to unleash the killing power of Akt in tumor cells treated with pro-oxidant drugs.
Subject(s)
Cell Lineage , Eukaryotic Initiation Factor-2/metabolism , Oxidative Stress , Phosphoserine/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Activating Transcription Factor 4/metabolism , Animals , Cell Death/drug effects , Cell Lineage/drug effects , Cell Survival/drug effects , Enzyme Activation/drug effects , Eukaryotic Initiation Factor-2/deficiency , Gene Deletion , Humans , Mechanistic Target of Rapamycin Complex 1 , Mice , Models, Biological , Multiprotein Complexes/metabolism , Oxidants/pharmacology , Oxidative Stress/drug effects , Phosphorylation/drug effects , Protein Serine-Threonine Kinases/metabolism , Sirolimus/pharmacology , TOR Serine-Threonine Kinases/metabolism , eIF-2 Kinase/metabolismABSTRACT
The eukaryotic cell responds to various forms of environmental stress by adjusting the rates of mRNA translation thus facilitating adaptation to the assaulting stress. One of the major pathways that control protein synthesis involves the phosphorylation of the α-subunit of eukaryotic initiation factor eIF2 at serine 51. Different forms of DNA damage were shown to induce eIF2α phosphorylation by using PERK, GCN2 or PKR. However, the specificity of the eIF2α kinases and the biological role of eIF2α phosphorylation pathway in the DNA damage response (DDR) induced by chemotherapeutics are not known. Herein, we show that PKR is the eIF2α kinase that responds to DDR induced by doxorubicin. We show that activation of PKR integrates two signaling pathways with opposing biological outcomes. More specifically, induction of eIF2α phosphorylation has a cytoprotective role, whereas activation of c-jun N-terminal kinase (JNK) by PKR promotes cell death in response to doxorubicin. We further show that the proapoptotic effects of JNK activation prevail over the cytoprotection mediated by eIF2α phosphorylation. These findings reveal that PKR can be an important inducer of cell death in response to chemotherapies through its ability to act independently of eIF2α phosphorylation.
Subject(s)
Antibiotics, Antineoplastic/pharmacology , Apoptosis , Doxorubicin/pharmacology , Eukaryotic Initiation Factor-2/metabolism , eIF-2 Kinase/metabolism , Animals , Cell Line , Cytoprotection , DNA Damage , DNA Repair , Humans , Mice , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , Signal Transduction , eIF-2 Kinase/geneticsABSTRACT
The interferon-induced antiviral state is mediated by interferon-stimulated genes that are upregulated in concert after stimulation by type I interferons. Because so many viruses encode strategies to inactivate the interferon-inducible double-stranded RNA (dsRNA)-dependent protein kinase PKR, this protein is likely to be a major player in antiviral defense. Here we demonstrate the increased susceptibility of PKR-/- animals to vesicular stomatitis virus (VSV) by the intranasal route, but also demonstrate that the protective effects of PKR are mouse strain dependent. We have found the difference between wild-type-BALB/c and 129SvEv animals to be on the order of 5 logs, with high levels of virus present in the lungs of BALB/c but not 129SvEv animals. To evaluate the sensitivity of PKR-/- mice to VSV clearly, the PKR mutation was bred onto the resistant 129SvEv background. The increased sensitivity of PKR-/- mice, compared to PKR+/+ strain-matched controls, is on the order of 10-fold as measured by median lethal dose (LD50). PKR-/- 129 mice support VSV replication in the lung unlike controls. While this result clearly demonstrates an important role for PKR in protection against VSV infection of the lung, it also underlines the importance of other host factors in containing a viral infection.
Subject(s)
Nose/virology , Rhabdoviridae Infections/immunology , Vesicular stomatitis Indiana virus , eIF-2 Kinase/physiology , Animals , Brain/virology , Interferon-alpha/biosynthesis , Interferon-beta/biosynthesis , Lung/virology , Mice , Mice, Inbred BALB C , Species SpecificityABSTRACT
PGs are regulators of a plethora of uterine functions during reproductive processes, including uterine contractility. In bovine uterus, the rate-limiting step in PG synthesis is catalyzed by the PG endoperoxide G/H synthase (PGHS) enzymes. It has previously been established that PGHS-2 isoform expression is affected by the ruminant-specific interferon (IFN)-tau in bovine endometrial cells. Here, we show that PGHS-2 mRNA and protein levels are induced by IFN-tau in primary cell cultures from bovine myometrium. Treatment with recombinant bovine IFN-tau induces the activation of the JAK-STAT and p38 MAPK pathways in bovine myometrial cells. Inhibition of the p38 pathway by the specific inhibitor SB203580 strongly decreases PGHS-2 mRNA and protein expression without affecting the phosphorylation and DNA-binding of transcription factors STAT-1 and STAT-2. The p38 pathway regulates PGHS-2 expression at the posttranscriptional level, because the presence of SB203580 results in the destabilization of IFN-tau-induced PGHS-2 mRNA. Taken together, these data demonstrate the ability of IFN-tau to induce the activation of the JAK-STAT pathway in a manner similar to other types of IFN (i.e. alpha, beta, and gamma) and to regulate PGHS-2 mRNA stability through the activation of the p38 pathway. These findings provide new insights into the physiological function of IFN-tau, in regard to regulation of specific genes associated with myometrial contractility.
Subject(s)
Interferon Type I/pharmacology , Mitogen-Activated Protein Kinases/metabolism , Myometrium/metabolism , Pregnancy Proteins/pharmacology , Prostaglandin-Endoperoxide Synthases/metabolism , Animals , Cattle , Cells, Cultured , DNA-Binding Proteins/metabolism , Enzyme Activation/physiology , Female , Interferon-Stimulated Gene Factor 3 , Myometrium/cytology , Myometrium/drug effects , Prostaglandins/biosynthesis , STAT1 Transcription Factor , Trans-Activators/metabolism , Transcription Factors/metabolism , Up-Regulation , p38 Mitogen-Activated Protein KinasesSubject(s)
Eukaryotic Cells/metabolism , Protein Biosynthesis/physiology , Animals , Artifacts , Binding Sites/physiology , Genes , Genetic Vectors , Humans , Peptide Initiation Factors/metabolism , RNA Processing, Post-Transcriptional/physiology , RNA, Messenger/metabolism , RNA, Transfer/metabolism , RNA, Viral/metabolism , Reproducibility of Results , Research Design , Ribosomes/metabolismABSTRACT
The interferon (IFN)-inducible double stranded (ds) RNA-activated protein kinase PKR plays an important role in protein synthesis by modulating the phosphorylation of the alpha-subunit of eukaryotic initiation fact 2 (eIF-2 alpha). In addition to translational control, PKR has been implicated in several signaling pathways leading to gene transcription. For example, PKR induces I kappa B alpha kinase (IKK) activity and I kappa B alpha phosphorylation leading to the induction of NF-kappa B-mediated gene transcription. Recent findings suggested that NF-kappa B activation by PKR does not require the catalytic activity of the kinase. Here, we provide novel evidence that induction of IKK and NF-kappa B activities proceeds independently of the dsRNA-binding properties of PKR and also verify the kinase-free role of PKR in this process. We also show that the effects of PKR mutants on IKK and NF-kappa B activation are independent of cell transformation but are dependent on the amount of the mutant PKR proteins expressed in cells. These data strongly support an indirect role of PKR in I kappa B alpha phosphorylation by modulating IKK activity through pathways that do not utilize the enzymatic and dsRNA-binding properties of PKR.
Subject(s)
Interferons/pharmacology , Protein Serine-Threonine Kinases/metabolism , RNA, Double-Stranded/metabolism , eIF-2 Kinase/physiology , 3T3 Cells , Animals , Catalysis , Cell Transformation, Neoplastic , DNA/metabolism , Enzyme Activation , Humans , I-kappa B Kinase , Mice , Mitogen-Activated Protein Kinase 8 , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , Phosphorylation , Transcriptional ActivationABSTRACT
Human papillomaviruses (HPV) infect mucosal and cutaneous epithelium resulting in several types of pathologies, most notably, cervical cancer. Persistent infection with sexually transmitted oncogenic HPV types represents the major risk factor for the development of cervical cancer. The development of HPV-associated cervical cancer has been closely linked to the expression of the viral oncogenes E6 and E7 in the tumor cells. The major viral oncoproteins, E6 and E7, target the cellular tumor suppressor gene products p53 and Rb, respectively. As detailed within, these interactions result in the stimulation of proliferation and the inhibition of apoptosis, thus representing major oncogenic insults to the infected cell. In addition to mediating transformation, the E6 and E7 genes also play significant roles in altering the immune response against infected cells by suppressing interferon (IFN) expression and signaling. At the clinical level, IFNs have been used in the treatment of HPV-associated cervical intraepithelial neoplasia (CIN) or cervical cancers with mixed results. The success of the treatment is largely dependent on the subtype of HPV and the immune response of the patients. Despite this inefficiency, the increasing knowledge about the regulation of IFN signaling pathways at molecular level may hold a promise for the use of new therapeutic strategies against HPV infection. Studies on the regulation of the function of IFN-inducible gene products by the E6 and E7 may lead to the development of new therapeutic approaches based on strategies that modify the function of the HPV oncoproteins and restore IFN-signaling pathways through endogenous control mechanisms.
Subject(s)
Interferons/immunology , Interferons/physiology , Papillomaviridae/immunology , Papillomaviridae/metabolism , Papillomavirus Infections/immunology , Signal Transduction , Tumor Virus Infections/immunology , Animals , Apoptosis , Base Sequence , Cell Division , Cell Transformation, Neoplastic , Female , Humans , Interferons/therapeutic use , Oncogene Proteins, Viral/metabolism , Papillomaviridae/genetics , Papillomavirus Infections/drug therapy , Papillomavirus Infections/metabolism , Papillomavirus Infections/pathology , Receptors, Interferon/metabolism , Tumor Virus Infections/drug therapy , Tumor Virus Infections/metabolism , Tumor Virus Infections/pathologyABSTRACT
The double-stranded RNA (dsRNA)-activated protein kinase PKR (protein kinase dsRNA-dependent) plays an important role in the regulation of protein synthesis by phosphorylating the alpha-subunit of eukaryotic initiation factor 2. Through this activity, PKR is thought to mediate the antiviral and antiproliferative actions of interferon. Here, we show that the human T cell leukemia Jurkat cells express an alternatively spliced form of PKR with a deletion of exon 7 (PKRDeltaE7), resulting in a truncated protein that retains the two dsRNA-binding motifs. PKRDeltaE7 exhibits a dominant negative function by inhibiting both PKR autophosphorylation and eukaryotic initiation factor 2 alpha-subunit phosphorylation in vitro and in vivo. Reverse transcriptase-polymerase chain reaction assays showed that PKRDeltaE7 is expressed in a broad range of human tissues at variable levels. Interestingly, expression of PKRDeltaE7 is higher in Jurkat cells than in normal peripheral blood mononuclear cells, raising the possibility of a role in cell proliferation and/or transformation. Thus, expression of alternatively spliced forms of PKR may represent a novel mechanism of PKR autoregulation with important implications in the control of cell proliferation.
Subject(s)
Alternative Splicing , Genes, Dominant , Interferons/metabolism , eIF-2 Kinase/genetics , eIF-2 Kinase/metabolism , Amino Acid Sequence , Base Sequence , Blotting, Western , Cell Division , Cloning, Molecular , DNA, Complementary/metabolism , Exons , Fibroblasts/metabolism , Galactose/metabolism , Genes, Reporter , Glucose/metabolism , HeLa Cells , Humans , Jurkat Cells , Leukocytes, Mononuclear/metabolism , Models, Biological , Models, Genetic , Molecular Sequence Data , Phosphorylation , Phosphoserine/metabolism , Point Mutation , Protein Structure, Tertiary , RNA/metabolism , RNA-Binding Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Tissue Distribution , Transfection , Vaccinia virus/geneticsABSTRACT
We have previously reported a physical association between STAT1 and the protein kinase double-stranded RNA-activated protein kinase (PKR). PKR inhibited STAT1 function in a manner independent of PKR kinase activity. In this report, we have further characterized the properties of both molecules by mapping the sites of their interaction. A STAT1 mutant unable to interact with PKR displays enhanced interferon gamma (IFN-gamma)-induced transactivation capacity compared with STAT1. This effect appears to be mediated by the higher capacity of STAT1 mutant to heterodimerize with STAT3. Furthermore, expression of STAT1 mutant in STAT1(-/-) cells enhances both the antiviral and antiproliferative effects of IFNs as opposed to STAT1. We also provide evidence that STAT1 functions as an inhibitor of PKR in vitro and in vivo. That is, phosphorylation of eIF-2alpha is enhanced in STAT1(-/-) than STAT1(+/+) cells in vivo, and this correlates with higher activation capacity of PKR in STAT1(-/-) cells. Genetic experiments in yeast demonstrate the inhibition of PKR activation and eIF-2alpha phosphorylation by STAT1 but not by STAT1 mutant. These data substantiate our previous findings on the inhibitory effects of PKR on STAT1 and implicate STAT1 in translational control through the modulation of PKR activation and eIF-2alpha phosphorylation.
Subject(s)
Antiviral Agents/pharmacology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Mutation , Trans-Activators/genetics , Trans-Activators/metabolism , eIF-2 Kinase/metabolism , Amino Acids/chemistry , Binding Sites , Cell Division/drug effects , Cell Line , DNA/metabolism , DNA-Binding Proteins/chemistry , Eukaryotic Initiation Factor-2/metabolism , Gene Expression Regulation , Glutathione Transferase/metabolism , HeLa Cells , Humans , Immunoblotting , Interferon-gamma/metabolism , Mutagenesis , Phosphorylation , Plasmids/metabolism , Precipitin Tests , Protein Binding , Protein Biosynthesis , STAT1 Transcription Factor , Time Factors , Trans-Activators/chemistry , Transcription, Genetic , Transcriptional Activation , TransfectionABSTRACT
The double-stranded (ds) RNA activated protein kinase PKR is an interferon (IFN)-inducible serine/threonine protein that regulates protein synthesis through the phosphorylation of the alpha subunit of translation initiation factor 2 (eIF-2alpha). PKR activation in cells is induced by virus infection or treatment with dsRNA and is modulated by a number of viral and cellular factors. To better understand the mechanisms of PKR action we have analyzed and compared the mode of PKR activation in a number of cell lines of different histological origin. Here we show that PKR activation and phosphorylation of eIF-2alpha are both diminished in various virus-transformed and nontransformed human T cells. Priming of T cells with IFN does not restore PKR activation. In vitro kinase assays show that the diminished PKR activation in T cells correlates with the presence of a 60-kDa (p60) phosphoprotein coimmunoprecipitated with PKR. P60 is absent from PKR immunoprecipitates from non T cells. Incubation of active PKR with T cell extracts results in inhibition of PKR autophosphorylation, which is proportional to the amount of phosphorylated p60 in the kinase reactions. Treatment of T cells with proteasome inhibitors or incubation of PKR immunoprecipitates with phosphatase inhibitors does not restore PKR activation. However, phosphorylation of p60 is enhanced upon treatment with the phosphatase inhibitor microcystin. These data show that the impaired activation capacity of PKR in human T cells is exerted at the post-translational levels in a manner that is independent of cell transformation or virus infection.
Subject(s)
Interferons/pharmacology , Phosphoproteins/metabolism , T-Lymphocytes/drug effects , eIF-2 Kinase/metabolism , Adult , Biological Factors/pharmacology , Cell Line, Transformed , Enzyme Induction/drug effects , Eukaryotic Initiation Factor-2/metabolism , Gene Expression Regulation, Neoplastic/drug effects , HeLa Cells , Humans , Jurkat Cells/drug effects , Jurkat Cells/enzymology , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Phosphoproteins/isolation & purification , Phosphorylation , Protein Processing, Post-Translational , T-Lymphocytes/enzymology , Transfection , eIF-2 Kinase/antagonists & inhibitors , eIF-2 Kinase/geneticsABSTRACT
The double-stranded RNA-dependent protein kinase PKR plays a central role in IFN-mediated antiviral response. The ability of PKR mutants to transform rodent fibroblasts led to the hypothesis that PKR acts as a tumor suppressor. Recent studies have identified an expanding network of PKR signaling partners, including signal transducers and activators of transcription 1 (STAT1), p53, and IkappaB-kinase. Here we demonstrate that PKR is involved in the cellular response to genotoxic stress. PKR-deficient mouse-embryonic fibroblasts (PKR-/-) are hypersensitive to bulky adduct DNA damage caused by cisplatin, melphalan, and UV radiation but not to other DNA-damaging agents such as Adriamycin. PKR-deficient cells are highly susceptible to cisplatin-induced apoptosis. They demonstrate retarded cisplatin adduct removal kinetics. Most strikingly, PKR localizes to the nucleus rapidly upon cisplatin treatment. Restoration of PKR in PKR-/- cells results in resistance to cisplatin and enhanced cell capacity to remove cisplatin DNA adducts. We conclude that PKR has a function in the regulation of cellular response to bulky adduct-inducing agents, possibly by modulating DNA repair mechanisms.
Subject(s)
DNA Adducts/metabolism , Interferons/metabolism , RNA, Double-Stranded/metabolism , eIF-2 Kinase/metabolism , eIF-2 Kinase/physiology , Animals , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents, Alkylating/pharmacokinetics , Apoptosis , Cisplatin/pharmacokinetics , DNA/drug effects , DNA/radiation effects , DNA Repair , Dose-Response Relationship, Drug , Doxorubicin/pharmacokinetics , Fibroblasts/metabolism , Fibroblasts/pathology , Genotype , Humans , Immunoblotting , Immunohistochemistry , Kinetics , Melphalan/pharmacokinetics , Mice , Microscopy, Fluorescence , Retroviridae/genetics , Signal Transduction , Time Factors , Tumor Cells, Cultured , Ultraviolet Rays , eIF-2 Kinase/geneticsABSTRACT
We have examined the effects of human papilloma virus (HPV) E6 proteins on interferon (IFN) signaling. Here we show that expression of the 'malignant' HPV-18 E6 in human HT1080 cells results in inhibition of Jak-STAT activation in response to IFN-alpha but not IFN-gamma. This inhibitory effect is not shared by the 'benign' HPV-11 E6. The DNA-binding and transactivation capacities of the transcription factor ISGF3 are diminished in cells expressing HPV-18 E6 after IFN-alpha treatment as a result of decreased tyrosine phosphorylation of Tyk2, STAT2 and STAT1. However, HPV-18 E6 does not affect the induction of tyrosine phosphorylation and DNA-binding of STAT1 by IFN-gamma. In addition, HPV E6 proteins physically interact with Tyk2. This interaction takes place preferably with HPV-18 E6 and to a lesser extent with HPV-11 E6. The E6/Tyk2 interaction requires the JH6-JH7 domains of Tyk2, which are important for Tyk2 binding to the cytoplasmic portion of IFN-alpha receptor 1 (IFNAR1). These findings demonstrate an inhibitory role of HPV-18 E6 in the IFN-alpha-induced Jak-STAT pathway, which may be explained, at least in part, by the ability of E6 to interact with and impair Tyk2 activation.
Subject(s)
Interferon-alpha/physiology , Oncogene Proteins, Viral/physiology , Papillomaviridae/physiology , Protein-Tyrosine Kinases/physiology , Proteins/metabolism , Proto-Oncogene Proteins , Trans-Activators/physiology , Cell Line , DNA-Binding Proteins/physiology , Enzyme Activation , Humans , Interferon-Stimulated Gene Factor 3 , Interferon-Stimulated Gene Factor 3, gamma Subunit , Interferon-alpha/genetics , Interferon-gamma/genetics , Interferon-gamma/physiology , Janus Kinase 2 , Multienzyme Complexes/physiology , Phosphorylation , Protein-Tyrosine Kinases/chemistry , Protein-Tyrosine Kinases/isolation & purification , Protein-Tyrosine Kinases/metabolism , Proteins/chemistry , Proteins/isolation & purification , Proteins/physiology , STAT1 Transcription Factor , STAT2 Transcription Factor , Signal Transduction/physiology , TYK2 Kinase , Transcription Factors/physiology , Tumor Cells, CulturedABSTRACT
The interferon (IFN)-inducible double-stranded (ds) RNA-dependent protein kinase PKR plays a role in the regulation of gene expression through its capacity to phosphorylate the translation initiation factor eIF-2 and to inhibit protein synthesis. In addition to translational control, PKR has been implicated in the regulation of gene expression at the transcriptional level. In this regard, we have reported that PKR participates in IFN-and dsRNA-mediated signaling pathways by interacting with and modulating the transcriptional activity of the signal transducer and activator of transcription STAT1 [Wong, A.H.-T., Tam, N.W.N., Yang, Y.-L., Cuddihy, A.R., Li, S., Kirchhoff, S., Hauser, H., Decker, T. & Koromilas, A.E. (1997) EMBO J. 16, 1291-1304]. Here we report that the STAT1 protein is upregulated in cells lacking PKR (PKR-/-) and in cells expressing dominant negative PKR mutants. This upregulation is specific for STAT1 as increased expression is not observed for other STAT proteins. The inhibitory effect of PKR on STAT1 expression is exerted at the post-translational level because PKR-/- cells exhibit higher STAT1 protein stability than PKR+/+ cells.
Subject(s)
DNA-Binding Proteins/metabolism , Trans-Activators/metabolism , Up-Regulation , eIF-2 Kinase/genetics , Animals , Catalysis , Cell Line , Genes, Dominant , Humans , Mice , RNA/metabolism , STAT1 Transcription FactorABSTRACT
The tumor suppressor p53 is a multifunctional protein that plays a critical role in modulating cellular responses upon DNA damage or other stresses. These functions of p53 are regulated both by protein-protein interactions and phosphorylation. The double-stranded RNA activated protein kinase PKR is a serine/threonine kinase that modulates protein synthesis through the phosphorylation of translation initiation factor eIF-2alpha. PKR is an interferon (IFN)-inducible protein that is thought to mediate the anti-viral and anti-proliferative effects of IFN via its capacity to inhibit protein synthesis. Here we report that PKR physically associates with p53. The interaction of PKR with p53 is enhanced by IFNs and upon conditions that p53 acquires a wild type conformation. PKR/p53 complex formation in vitro requires the N-terminal regulatory domain of PKR and the last 30 amino acids of the C-terminus of human p53. In addition, p53 may function as a substrate of PKR since phosphorylation of human p53 on serine392 is induced by activated PKR in vitro. These novel findings raise the possibility of a functional interaction between PKR and p53 in vivo, which may account, at least in part, for the ability of each protein to regulate gene expression at both the transcriptional and the translational levels.
Subject(s)
RNA, Double-Stranded/genetics , Serine/metabolism , Tumor Suppressor Protein p53/metabolism , eIF-2 Kinase/metabolism , Amino Acid Sequence , Animals , Cell Line , Humans , Molecular Sequence Data , Phosphorylation , Precipitin Tests , Protein Structure, TertiaryABSTRACT
The tumor suppressor p53 plays a key role in inducing G1 arrest and apoptosis following DNA damage. The double-stranded-RNA-activated protein PKR is a serine/threonine interferon (IFN)-inducible kinase which plays an important role in regulation of gene expression at both transcriptional and translational levels. Since a cross talk between IFN-inducible proteins and p53 had already been established, we investigated whether and how p53 function was modulated by PKR. We analyzed p53 function in several cell lines derived from PKR+/+ and PKR-/- mouse embryonic fibroblasts (MEFs) after transfection with the temperature-sensitive (ts) mutant of mouse p53 [p53(Val135)]. Here we report that transactivation of transcription by p53 and G0/G1 arrest were impaired in PKR-/- cells upon conditions that ts p53 acquired a wild-type conformation. Phosphorylation of mouse p53 on Ser18 was defective in PKR-/- cells, consistent with an impaired transcriptional induction of the p53-inducible genes encoding p21(WAF/Cip1) and Mdm2. In addition, Ser18 phosphorylation and transcriptional activation by mouse p53 were diminished in PKR-/- cells after DNA damage induced by the anticancer drug adriamycin or gamma radiation but not by UV radiation. Furthermore, the specific phosphatidylinositol-3 (PI-3) kinase inhibitor LY294002 inhibited the induction of phosphorylation of Ser18 of p53 by adriamycin to a higher degree in PKR+/+ cells than in PKR-/- cells. These novel findings suggest that PKR enhances p53 transcriptional function and implicate PKR in cell signaling elicited by a specific type of DNA damage that leads to p53 phosphorylation, possibly through a PI-3 kinase pathway.
Subject(s)
Transcriptional Activation , Tumor Suppressor Protein p53/metabolism , eIF-2 Kinase/metabolism , Animals , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins , DNA Damage , G1 Phase , Mice , Mollusk Venoms , Mutation , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Receptor Cross-Talk , Resting Phase, Cell Cycle , Signal Transduction , Transcription, Genetic , eIF-2 Kinase/geneticsABSTRACT
The interferon-inducible, double-stranded RNA-dependent protein kinase PKR has been implicated in anti-viral, anti-tumor, and apoptotic responses. Others have attempted to examine the requirement of PKR in these roles by targeted disruption at the amino terminal-encoding region of the Pkr gene. By using a strategy that aims at disruption of the catalytic domain of PKR, we have generated mice that are genetically ablated for functional PKR. Similar to the other mouse model of Pkr disruption, we have observed no consequences of loss of PKR on tumor suppression. Anti-viral response to influenza and vaccinia also appeared to be normal in mice and in cells lacking PKR. Cytokine signaling in the type I interferon pathway is normal but may be compromised in the erythropoietin pathway in erythroid bone marrow precursors. Contrary to the amino-terminal targeted Pkr mouse, tumor necrosis factor alpha-induced apoptosis and the anti-viral apoptosis response to influenza is not impaired in catalytic domain-targeted Pkr-null cells. The observation of intact eukaryotic initiation factor-2alpha phosphorylation in these Pkr-null cells provides proof of rescue by another eukaryotic initiation factor-2alpha kinase(s).
Subject(s)
eIF-2 Kinase/metabolism , Animals , Antiviral Agents , Apoptosis , Catalytic Domain , Cytokines/metabolism , Eukaryotic Initiation Factor-2/metabolism , Interferons/metabolism , Mice , Mice, Transgenic , Mutagenesis , Orthomyxoviridae , Oxidative Stress , Phosphorylation , Signal Transduction , Vaccinia virus , eIF-2 Kinase/geneticsABSTRACT
The interferon-inducible double-stranded RNA protein kinase PKR controls protein synthesis through the phosphorylation of eukaryotic translation initiation factor (eIF)-2. In addition to its demonstrated role in translational control, several reports have suggested a transcriptional role for PKR. Here we report that PKR is involved in IFN- and dsRNA-signaling pathways by modulating the function of the signal transducer and activator of transcription STAT1. We also show that PKR associates with STAT1 in mouse and human cells. The association is not a kinase-substrate interaction since STAT1 phosphorylation is not modified by PKR in vitro or in vivo. In addition, the formation of the PKR-STAT1 complex is not dependent upon the enzymatic activity of PKR but does require the dsRNA-binding domain of PKR. Moreover, there is a concomitant decrease in PKR-STAT1 interaction and increase in STAT1 DNA binding in response to IFNs or dsRNA. These findings suggest that PKR plays an important role in IFN and dsRNA-signaling pathways by modulating the transcriptional function of STAT1.
Subject(s)
DNA-Binding Proteins/metabolism , Interferons/metabolism , Protein Serine-Threonine Kinases/metabolism , RNA, Double-Stranded/metabolism , Trans-Activators/metabolism , 3T3 Cells , Animals , Base Sequence , DNA/genetics , DNA/metabolism , HeLa Cells , Humans , Mice , Mutation , Phosphorylation , Protein Binding , Protein Serine-Threonine Kinases/genetics , STAT1 Transcription Factor , Signal Transduction , Transcriptional Activation , Transfection , eIF-2 KinaseABSTRACT
Replication of the human immunodeficiency virus type 1 (HIV-1) is inhibited by interferons (IFNs), and the IFN-inducible protein kinase PKR is thought to mediate this effect by regulating protein synthesis. Here we report that ectopic expression of dominant negative PKR mutants in Jurkat cells induces HIV-1 replication. Specifically, expression of CD4 is upregulated by the PKR mutants, and this correlates with an induction of HIV-1 binding and proviral DNA synthesis upon HIV-1 infection. Moreover, activation of NF-kappaB was induced by an RNA binding-defective mutant of PKR. Thus, it appears that PKR, in addition to translational control, is involved in HIV-1 replication by modulating virus binding through the regulation of CD4 expression and virus gene expression through the activation of NF-kappaB.
Subject(s)
CD4 Antigens/genetics , Gene Expression Regulation, Viral , HIV Infections/virology , HIV-1/physiology , Protein Serine-Threonine Kinases/genetics , Virus Replication , Gene Transfer Techniques , Humans , Interferons/pharmacology , Jurkat Cells , Protein Serine-Threonine Kinases/agonists , eIF-2 KinaseABSTRACT
PKR is an interferon (IFN)-induced serine/threonine protein kinase that regulates protein synthesis through phosphorylation of eukaryotic translation initiation factor-2 (eIF-2). In addition to its demonstrated role in translational control, recent findings suggest that PKR plays an important role in regulation of gene transcription, as PKR phosphorylates I kappa B alpha upon double-stranded RNA treatment resulting in activation of NF-kappa B DNA binding in vitro (Kumar, A., Haque, J., Lacoste, J., Hiscott, J., and Williams, B.R.G. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 6288-6292). To further investigate the role of PKR in transcriptional signaling, we expressed the wild type human PKR and a catalytically inactive dominant negative PKR mutant in the murine pre-B lymphoma 70Z/3 cells. Here, we report that expression of wild type PKR had no effect on kappa-chain transcriptional activation induced by lipopolysaccharide or IFN-gamma. However, expression of the dominant negative PKR mutant inhibited kappa gene transcription independently of NF-kappa B activation. Phosphorylation of eIF-2 alpha was not increased by lipopolysaccharide or IFN-gamma, suggesting that PKR mediates kappa gene transcriptional activation without affecting protein synthesis. Our findings further support a transcriptional role for PKR and demonstrate that there are at least two distinct PKR-mediated signal transduction pathways to the transcriptional machinery depending on cell type and stimuli, NF-kappa B-dependent and NF-kappa B-independent.
Subject(s)
Gene Expression Regulation, Neoplastic , Genes, Immunoglobulin , Immunoglobulin kappa-Chains/genetics , Protein Serine-Threonine Kinases/metabolism , Signal Transduction , Animals , Base Sequence , Enzyme Induction , Eukaryotic Initiation Factor-2/metabolism , Gene Expression Regulation, Developmental , Humans , Immunoglobulin M/biosynthesis , Lymphoma, B-Cell , Mice , Molecular Sequence Data , Mutation , NF-kappa B/metabolism , Phosphorylation , Precancerous Conditions , Protein Serine-Threonine Kinases/genetics , RNA, Neoplasm/biosynthesis , Receptors, Antigen, B-Cell/biosynthesis , Recombinant Proteins/metabolism , Sequence Deletion , Transcription, Genetic , Tumor Cells, Cultured , eIF-2 KinaseABSTRACT
Expression of the tumor suppressor IRF-1 results in the inhibition of cell growth and transcriptional activation of the IFN-beta gene. IFN production is not responsible for the IRF-1 mediated cell growth inhibition. It is shown here that activation of the IRF-1 causes induction of PKR expression. PKR is a serine/threonine kinase with tumor suppressor activity. IRF-1 mediated cell growth inhibition and IFN induction correlates with PKR expression. A catalytically inactive dominant negative PKR mutant abolishes both activities of IRF-1. These data demonstrate that the tumor suppressor activity of IRF-1 is mediated, at least in part, by PKR.